701 E Pratt St
Baltimore, MD 21202
Join us to hear from the CEO’s of three of the most innovative companies that are developing novel therapeutics and drugs for hard-to-treat and multi-drug resistant bacteria and other infectious agents. Panelists will discuss the promises and challenges they face bringing these new therapies to the bedside.